IGF2BP2 modulates tumour progression by serving as a post‐transcriptional regulatory factor for the target mRNAs of MYC,34 HMGA2,44 MIS12,45 SOX237 and FEN1.35 The gene discussed is MYC; the disease is neoplasm.